Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Bladder Cancer

  Free Subscription


1 Acupunct Med
1 Am J Clin Pathol
1 Asian J Androl
1 Cancer Cell Int
1 Cancer Res
1 Cell Biol Toxicol
1 Elife
2 Eur J Cancer
1 Eur Urol
1 Eur Urol Oncol
1 Exp Cell Res
1 Front Cell Dev Biol
1 Georgian Med News
2 IJU Case Rep
1 J Clin Invest
1 J Comp Pathol
1 J Healthc Eng
1 Pathol Res Pract
4 Sci Rep
1 Urol Case Rep
1 Urol Int
2 Urologe A
1 Urologiia
1 World J Urol
2 Zhonghua Wai Ke Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acupunct Med

  1. WANG YZ, Yang JX, Wang JX
    Electroacupuncture for ileus following laparoscopic radical cystectomy and Bricker urinary diversion: a case report.
    Acupunct Med. 2021;39:545-546.

    Am J Clin Pathol

  2. BABU S, Kim NW, Wu M, Chan I, et al
    Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis.
    Am J Clin Pathol. 2021;156:926-933.
    PubMed         Abstract available

    Asian J Androl

  3. GUO P, Wang Y, Xie YF, Lv TB, et al
    Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China.
    Asian J Androl. 2021 Nov 2. pii: 329837. doi: 10.4103/aja202166.
    PubMed         Abstract available

    Cancer Cell Int

  4. LI T, Tong H, Yin H, Luo Y, et al
    Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming.
    Cancer Cell Int. 2021;21:597.
    PubMed         Abstract available

    Cancer Res

  5. JING W, Wang G, Cui Z, Xiong G, et al
    FGFR3 Destabilizes PD-L1 Via NEDD4 to Control T Cell-Mediated Bladder Cancer Immune Surveillance.
    Cancer Res. 2021 Nov 9. pii: 0008-5472.CAN-21-2362.
    PubMed         Abstract available

    Cell Biol Toxicol

  6. LI G, Guo BY, Wang HD, Lin GT, et al
    CircRNA hsa_circ_0014130 function as a miR-132-3p sponge for playing oncogenic roles in bladder cancer via upregulating KCNJ12 expression.
    Cell Biol Toxicol. 2021 Nov 9. pii: 10.1007/s10565-021-09668.
    PubMed         Abstract available


  7. WANG HT, Lee HW, Weng MW, Liu Y, et al
    The role of TAp63gamma and P53 point mutations in regulating DNA repair, mutational susceptibility and invasion of bladder cancer cells.
    Elife. 2021;10.
    PubMed         Abstract available

    Eur J Cancer

  8. MORI K, Pradere B, Moschini M, Mostafaei H, et al
    First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis.
    Eur J Cancer. 2021;151:35-48.
    PubMed         Abstract available

  9. BOUDIN L, Patient M, Romeo E, Blade JS, et al
    Lurbinectedin for metastatic small-cell bladder carcinoma.
    Eur J Cancer. 2021;151:1-2.

    Eur Urol

  10. MIRON B, Bukavina L, Plimack ER
    Placing Adjuvant Chemotherapy in the Evolving Paradigm of Perioperative Therapy for Bladder Cancer.
    Eur Urol. 2021 Nov 5. pii: S0302-2838(21)02121.

    Eur Urol Oncol

  11. LAUKHTINA E, Shim SR, Mori K, D'Andrea D, et al
    Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis.
    Eur Urol Oncol. 2021 Nov 6. pii: S2588-9311(21)00183.
    PubMed         Abstract available

    Exp Cell Res

  12. ZHAO F, Qin S, Huang L, Ding L, et al
    Long noncoding RNA AK023096 interacts with hnRNP-K and contributes to the maintenance of self-renewal in bladder cancer stem-like cells.
    Exp Cell Res. 2021;409:112909.
    PubMed         Abstract available

    Front Cell Dev Biol

  13. MAO W, Wang K, Sun S, Wu J, et al
    ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway.
    Front Cell Dev Biol. 2021;9:738364.
    PubMed         Abstract available

    Georgian Med News

    Georgian Med News. 2021;:17-21.
    PubMed         Abstract available

    IJU Case Rep

  15. ARAI T, Takeuchi N, Sazuka T, Sato H, et al
    Successful treatment of metastatic bladder cancer by gemcitabine-cisplatin re-challenge after pembrolizumab.
    IJU Case Rep. 2021;4:360-362.
    PubMed         Abstract available

  16. NODA M, Nakamura M, Kawai T, Sato Y, et al
    Early recurrence of bladder cancer in the colon after robot-assisted radical cystectomy: Disappearance following dose-dense methotrexate, vinblastine, doxorubicin and cisplatin treatment.
    IJU Case Rep. 2021;4:429-432.
    PubMed         Abstract available

    J Clin Invest

  17. TRUONG AS, Zhou M, Krishnan B, Utsumi T, et al
    Entinostat induces antitumor immune responses through immune editing of tumor neoantigens.
    J Clin Invest. 2021;131.
    PubMed         Abstract available

    J Comp Pathol

  18. VAN DER WEYDEN L, O'Donnell M, Plog S
    Histological Characterization of Feline Bladder Urothelial Carcinoma.
    J Comp Pathol. 2021;182:9-14.
    PubMed         Abstract available

    J Healthc Eng

  19. ZANG L
    Multi-Slice Spiral Computed Tomography Image Features under Hybrid Iterative Reconstruction Algorithm in Staging Diagnosis of Bladder Cancer.
    J Healthc Eng. 2021;2021:7733654.
    PubMed         Abstract available

    Pathol Res Pract

  20. YANG Y, Zhang G, Li J, Gong R, et al
    Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
    Pathol Res Pract. 2021;228:153676.
    PubMed         Abstract available

    Sci Rep

  21. GOTO K, Honda Y, Ikeda K, Takemoto K, et al
    Tumor heterogeneity evaluated by computed tomography detects muscle-invasive upper tract urothelial carcinoma that is associated with inflammatory tumor microenvironment.
    Sci Rep. 2021;11:14251.
    PubMed         Abstract available

  22. TOSEV G, Wahafu W, Reimold P, Damgov I, et al
    Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder.
    Sci Rep. 2021;11:14244.
    PubMed         Abstract available

  23. VON SIEBENTHAL M, Besic M, Gheinani AH, Akshay A, et al
    Urinary miRNA profiles discriminate between obstruction-induced bladder dysfunction and healthy controls.
    Sci Rep. 2021;11:10204.
    PubMed         Abstract available

  24. KIM TH, Lee CU, Kang M, Jeon HG, et al
    Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma.
    Sci Rep. 2021;11:7828.
    PubMed         Abstract available

    Urol Case Rep

  25. KATELARIS A, De Silva S, Thompson DJ
    The evolving role of multi-parametric MRI in the evaluation of bladder cancer: Revealing what lies beneath the surface.
    Urol Case Rep. 2021;40:101906.
    PubMed         Abstract available

    Urol Int

  26. PULLEN L, Kaspar C, Panic A, Hess J, et al
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort.
    Urol Int. 2021 Nov 10:1-6. doi: 10.1159/000519898.
    PubMed         Abstract available

    Urologe A

  27. JAHNEN M, Kirchhoff FP, Gschwend JE, Straub M, et al
    [Transurethral resection of the urinary bladder : Status quo and outlook on new developments].
    Urologe A. 2021;60:1416-1423.
    PubMed         Abstract available

  28. ROGHMANN F, Mayr R, Tully K, Engelmann S, et al
    [Early cystectomy-patient selection and technique].
    Urologe A. 2021;60:1424-1431.
    PubMed         Abstract available


  29. MORGOSHIIA TS, Kalashnikova VD
    [Professor Joachim Albarran. Urologist and scientist ahead of his time].
    Urologiia. 2021;:118-120.
    PubMed         Abstract available

    World J Urol

  30. DE LA ROSETTE J, Martov A, Hurle R, Favre G, et al
    Conventional white light imaging-assisted transurethral resection of bladder tumour (TURBT) versus IMAGE1S-assisted TURBT in non-muscle-invasive bladder cancer patients: trial protocol and 18 months results.
    World J Urol. 2021 Nov 6. pii: 10.1007/s00345-021-03866.
    PubMed         Abstract available

    Zhonghua Wai Ke Za Zhi

  31. AI K, Li Y
    [Immunotherapy for locally advanced or metastatic urothelial carcinoma: research advances and perspectives].
    Zhonghua Wai Ke Za Zhi. 2021;59:881-885.
    PubMed         Abstract available

  32. ZHANG F, Li YY, Shi ZZ, Wang CB, et al
    [Progress in treatment of PD-1/PD-L1 inhibitors for bladder cancer].
    Zhonghua Wai Ke Za Zhi. 2021;59:952-955.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.